Escalating need for personalized medicine, cost-efficient and rapid production of biodrugs, prospects of bioprinted organs, implants, and tissue reconstructions are the major drivers of the 3D bioprinters market. However, challenging site for organ printing technology is the rapid or accelerated tissue maturation process, where printed organ constructs should be rapidly fused, remodelled, and maturated toward a solid construct, ensuring mechanical rigidity for transplantation
Global 3D Bioprinters Market 2024
According to Goldstein Research, 3D Bioprinters market size is set to reach USD 1.24 billion by 2024, at a CAGR of 24% over the forecast years owing to elevated lifespan of individuals, inflation of chronic illnesses, rise in demand for tissue and organ transplants, adoption of IT in healthcare sector, limited number of organ donors, rapid advancement in 3D printing technology, and rising geriatric population.
On the basis of application, drug and medical research hold the considerable amount of market share owing to complex drug manufacturing processes which can be standardized through use of 3D printing in order to precisely control the droplet size and dose, high reproducibility, and the ability to produce dosage forms with complex drug-release profiles.
Geographically, North America dominates the 3D bioprinters market and is anticipated to reach the valuation of USD 0.56 billion by 2024. Japan-based, Xilloc Medical Company specializing in the biomedical printing of ceramics has successfully printed tissue that will assimilate with existing bone structures and within months new printing material i.e. calcium phosphate, implants will be done using this new technology will merge with natural bone.
Barriers & Controversies: Unrealistic Expectations
Expectations from the bioprinting technology are often exaggerated by media, government and even by researchers that lead to unrealistic projections regarding exciting possibilities becoming reality soon, for instance, organ printing. Although progress is ongoing but it requires vision, money and time for evolution into the anticipated applications. The biomedical sector is the most fertile target for 3D bioprinting discoveries its necessary to hold regard for what has already been achieved with expecting the overnight advancements.
Global 3D bioprinters market analysis report contains a detailed overview of the global 3D Bioprinters market in terms of market segmentation by technology, material and application.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.
Global 3D Bioprinters Market report also provides competitive outlook for some of the major players which includes profiling of companies such as Aspect Biosystems Ltd., Nano 3D Biosciences, Inc., Gesim, Envisiontec GmbH, Regenovo Biotechnology Co., Ltd., Organovo Holdings, Inc., Poietis, Regenhu Ltd., 3Dynamic Systems Ltd., Biobots, Cyfuse Biomedical K.K., Cellink, 3D Bioprinting Solutions, Digilab, InSphero, Luxexcel Group BV, TeVido BioDevices, Voxeljet, Stratasys Ltd., Solidscape, Materialise NV and Bio3D Technologies. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.
Overall, the report represents comprehensive synopsis on the global 3D Bioprinters market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.